Showing results (181-190 of 1,987) with videos related to
Sort By:
Pageof 199
Clinical Chemistry|February 1, 1976
Double-antibody enzyme immunoassay applied to human alpha 1-fetoproteinL Belanger, D Hamel, D Dufour, et al.Plant Physiology|November 1, 1994
Arabidopsis thaliana expresses three divergent Srp54 genesB Chu, J T Lindstrom, F C BelangerAmerican Journal of Clinical Oncology|April 1, 1995
Prolonged disease-free survival following surgical debulking and high-dose cisplatin/doxorubicin in a patient with bulky metastases from giant cell tumor of bone refractory to "standard" chemotherapyD J Stewart, R Belanger, R S BenjaminLeukemia Research|June 6, 2006
In vitro generation of tumor specific T cells that recognize a shared antigen of AML: molecular characterization of TCR genesMyra Coppage, Todd Belanger, Maurice Zauderer, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 28, 2004
Hyperoxia causes oxygen free radical-mediated membrane injury and alters myocardial function and hemodynamics in the newbornK S Bandali, M P Belanger, C WittnichArchives of Physical Medicine and Rehabilitation|July 7, 2009
Mild traumatic brain injury and posttraumatic stress disorder and their associations with health symptomsRodney D Vanderploeg, Heather G Belanger, Glenn CurtissApplied Optics|April 15, 2010
Orthogonality properties of phase conjugate optical resonatorsA Hardy, P A Belanger, A E SiegmanThe Canadian Journal of Cardiology|March 10, 2007
Newborn hearts are at greater 'metabolic risk' during global ischemia--advantages of continuous coronary washoutCarin Wittnich, Michael P Belanger, Karim S BandaliSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2021
Active by nature: exploring cancer survivors' exercise barriers, facilitators, preferences, and psychosocial benefits of engaging in outdoor physical activityIris A Lesser, C P Nienhuis, L BelangerThe Journal of Urology|October 1, 1987
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonistF Labrie, A Dupont, A Belanger, et al.Pageof 199